Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 16,808	$ 21,088
General and administrative	20,737	26,401
Loss on impairment of goodwill	29,517
Total operating expenses	67,062	47,489
Loss from operations	(67,062)	(47,489)
Other income (expense), net
Interest and investment income	1,110	237
Other income (expense), net	1,110	237
Net loss	$ (65,952)	$ (47,252)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (5.86)	$ (4.21)
Weighted average shares outstanding, basic (in Shares)	11,259,615	11,232,576
Other comprehensive income (loss):
Net unrealized (loss) gain on marketable debt securities	$ (477)	$ (211)
Other comprehensive income (loss)	(477)	(211)
Comprehensive Loss	$ (66,429)	$ (47,463)